1. Home
  2. DNLI vs AXTI Comparison

DNLI vs AXTI Comparison

Compare DNLI & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

N/A

Current Price

$18.42

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Logo AXT Inc

AXTI

AXT Inc

N/A

Current Price

$30.56

Market Cap

3.8B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DNLI
AXTI
Founded
2013
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
2017
1998

Fundamental Metrics

Financial Performance
Metric
DNLI
AXTI
Price
$18.42
$30.56
Analyst Decision
Strong Buy
Buy
Analyst Count
21
6
Target Price
$35.82
★ $82.77
AVG Volume (30 Days)
1.3M
★ 9.1M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.57
Revenue
N/A
★ $99,361,000.00
Revenue This Year
N/A
$167.93
Revenue Next Year
$204.90
$111.50
P/E Ratio
★ N/A
$61.09
Revenue Growth
N/A
★ 31.09
52 Week Low
$15.34
$8.84
52 Week High
$27.30
$143.16

Technical Indicators

Market Signals
Indicator
DNLI
AXTI
Relative Strength Index (RSI) 43.32 32.20
Support Level $18.24 $22.59
Resistance Level $21.45 $47.00
Average True Range (ATR) 0.94 5.24
MACD -0.10 -0.64
Stochastic Oscillator 24.50 3.15

Price Performance

Historical Comparison
DNLI
AXTI

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

Share on Social Networks: